Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Colombo N, Formelli F, Cantù MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, Decensi A. Colombo N, et al. Among authors: decensi a. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1914-9. doi: 10.1158/1055-9965.EPI-06-0183. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035399 Clinical Trial.
Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study.
Guerrieri-Gonzaga A, Botteri E, Lazzeroni M, Rotmensz N, Goldhirsch A, Varricchio C, Serrano D, Cazzaniga M, Bassi F, Luini A, Bagnardi V, Viale G, Mora S, Bollani G, Albertazzi E, Bonanni B, Decensi A. Guerrieri-Gonzaga A, et al. Among authors: decensi a. Ann Oncol. 2010 May;21(5):949-54. doi: 10.1093/annonc/mdp408. Epub 2009 Oct 25. Ann Oncol. 2010. PMID: 19858087 Free article.
Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study.
Guerrieri-Gonzaga A, Lazzeroni M, Botteri E, Serrano D, Rotmensz N, Varricchio MC, Cazzaniga M, Bollani G, Mora S, Montefrancesco C, Pruneri G, Viale G, Intra M, Galimberti V, Goldhirsch A, Bagnardi V, Bonanni B, DeCensi A. Guerrieri-Gonzaga A, et al. Among authors: decensi a. Ann Oncol. 2013 Jul;24(7):1859-1866. doi: 10.1093/annonc/mdt113. Epub 2013 Mar 26. Ann Oncol. 2013. PMID: 23532115 Free article.
An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab.
D'Amico M, Pagano M, Pasa A, Puntoni M, Clavarezza M, Gennari A, Gozza A, Zanardi S, Defferrari C, Provinciali N, Campazzi E, Campora S, Paleari L, Marra D, Petrera M, DeCensi A. D'Amico M, et al. Among authors: decensi a. Expert Opin Drug Saf. 2014 Nov;13(11):1437-42. doi: 10.1517/14740338.2014.960388. Epub 2014 Sep 16. Expert Opin Drug Saf. 2014. PMID: 25224760
Metformin: risk-benefit profile with a focus on cancer.
Provinciali N, Lazzeroni M, Cazzaniga M, Gorlero F, Dunn BK, DeCensi A. Provinciali N, et al. Among authors: decensi a. Expert Opin Drug Saf. 2015 Oct;14(10):1573-85. doi: 10.1517/14740338.2015.1084289. Epub 2015 Sep 11. Expert Opin Drug Saf. 2015. PMID: 26359221 Review.
274 results